# Impact of Reducose® on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)

> **NCT07333885** · NA · RECRUITING · sponsor: **Phynova Group Ltd** · enrollment: 120 (estimated)

## Conditions studied

- Glycemic Response
- Menopause Symptoms

## Interventions

- **DIETARY_SUPPLEMENT:** Reducose® (Mulberry leaf extract)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07333885
- **Lead sponsor:** Phynova Group Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-12
- **Primary completion:** 2026-06
- **Final completion:** 2026-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333885, "Impact of Reducose® on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07333885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*